SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists.
Feb 5, 2021
0
88
(HealthDay)—For patients hospitalized with COVID-19 and not receiving mechanical ventilation, the risk for death is reduced with transfusion of plasma with higher versus lower levels of anti-severe acute respiratory syndrome ...
Jan 19, 2021
0
5
A year after the coronavirus pandemic roared into the United States, the therapeutic options for COVID-19 remain limited, reinforcing the vital importance of the new vaccines.
Jan 11, 2021
0
3
Blood plasma from people recovering from COVID-19 could help prevent severe illness in older patients newly infected with the virus, a small new Argentinian study finds.
Jan 7, 2021
1
4
(HealthDay)—Early in the COVID-19 pandemic, anecdotal reports suggested that infusing very sick patients with the blood plasma of people who'd survived the disease might help boost outcomes.
Nov 25, 2020
0
2
The majority of people infected with SARS-CoV-2 appear to actively shed infectious virus for about 8 days, but there is a wide range of variability from person to person. Understanding how long people can remain actively ...
Nov 4, 2020
0
251
Plasma taken from the blood of people who have recovered from COVID-19 and given to people sick with the disease does not reduce their chances of getting seriously ill or dying, new research has found.
Oct 23, 2020
2
17
Donald Trump's brief stay in hospital in early October raised awareness—once again—of the variety of treatments being investigated for COVID-19.
Oct 22, 2020
0
4
Two US companies have applied for emergency approval for their lab-produced antibodies against COVID-19—and President Donald Trump has signaled his strong backing based on the fact he was treated with one of them.
Oct 8, 2020
0
4
Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19. ...
Sep 22, 2020
0
1
